IOTA Versus Pattern Recognition Method in Diagnosis of Ovarian Masses

To compare between the efficacy of IOTA simple rules and pattern recognition method in the differentiating between benign and malignant adnexal masses

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gynecology

Age range

40 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Kasr el aini hospital

Cairo, 12211, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ovarian mass more than 5 cm in size (confirmed by transvaginal or transabdominal ultrasonography in gynecology clinic)
The patient is candidate for abdominal exploration for ovarian Cystectomy or oophorectomy.

Exclusion criteria

Complicated ovarian masses.
Unfit for surgery.

Treatment and study plan

Transvaginal ultrasonography

Device

Primary outcomes

comparing the sensitivity of the IOTA versus the Pattern recognition in diagnosing the different types of ovarian masses

Time frame: 12 month

Sponsors and collaborators

Lead sponsor

Woman's Health University Hospital, Egypt

Other

Registry information

Official study title

The Diagnostic Value Of International Ovarian Tumour Analysis (IOTA) Simple Rules Versus the Pattern Recognition Method In Differentiating Between Malignant And Benign Adnexal Masses

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Jun 15, 2016
Registry last updated: Jan 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed